Effects of Preeclampsia on Maternal and Pediatric Health at 11 Years Postpartum

Stephanie E Chan1, Jessica Pudwell1, Graeme N Smith1

  • 1Department of Obstetrics and Gynecology, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada.

Insights

Preeclampsia (PE) is linked to increased cardiovascular risk factors and developmental delays in children approximately 11 years later. Early screening and intervention during pregnancy and postpartum are crucial for long-term health.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Developmental Pediatrics

Background:

  • Preeclampsia (PE) is a pregnancy complication with potential long-term health implications.
  • Cardiovascular risk (CVR) factors and childhood development are key areas of concern following PE.
  • Understanding the long-term effects of PE is crucial for maternal and child health outcomes.

Purpose of the Study:

  • To investigate the association between preeclampsia and cardiovascular risk factors approximately 11 years postpartum.
  • To assess the long-term impact of preeclampsia on childhood development.
  • To identify opportunities for early screening and intervention.

Main Methods:

  • A prospective cohort study comparing women with and without a history of preeclampsia.
  • Mailed surveys collected data on cardiovascular risk markers and child development using the Vineland-3 scale.
  • Statistical analysis compared CVR markers and developmental outcomes between PE and control groups.

Main Results:

  • Women with a history of preeclampsia showed significantly higher rates of hypertension (69.2%) compared to controls (21.4%) at 11 years postpartum.
  • Children born to mothers with preeclampsia had lower adaptive functioning scores (median 58) compared to control children (median 81).
  • These findings indicate persistent cardiovascular risks and developmental differences in offspring.

Conclusions:

  • Preeclampsia is associated with lasting cardiovascular risks and altered childhood development up to 11 years postpartum.
  • Pregnancy and postpartum periods represent critical windows for maternal and child health screening.
  • Early interventions can promote health preservation and disease prevention in mothers and children affected by PE.
Abstract

Related Concept Videos

Health Literacy01:21

Health Literacy

Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative...
5.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Purpose of Health Records I01:11

Purpose of Health Records I

The vital purpose of health records is to provide a complete and accurate account of a patient's medical history, including communication, diagnostic and therapeutic orders, care planning, research, and quality review.
Here's a breakdown of how health records serve these purposes:
1.8K
Purpose of Health Records II01:19

Purpose of Health Records II

Health records serve various essential purposes in the healthcare system. Here are some key purposes:
1.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226